miRNEST 2.0: an integrative microRNA resource miRNEST 2.0, an integrative microRNA resource :: Browse



Data derived from PhenomiR


PubMed IDdiseasedisease classtissueexpressionfoldchange maxfoldchange mingenesstudy designmethod
16966691 Pancreatic cancer - 260350 (Pancreatic endocrine tumors - 0) Cancer pancreas miRNA overexpression - 6.61 - Patient study phenotype-control miRNA microarray
17761882 Parkinson disease - 168600 Neurological midbrain miRNA overexpression - 1.44 - Patient study phenotype-control quantitative PCR
18458333 Ovarian cancer - 604370 (Epithelial ovarian cancer - 0) Cancer ovary miRNA downregulation - - - Cell culture study miRNA microarray
18381414 Squamous cell carcinoma, head and neck - 601400 (Oral squamous carcinoma (OSCC) - 0) Cancer HSC-3 cell miRNA downregulation - - - Cell culture study quantitative PCR
18089852 Rapp-Hodgkin syndrome - 129400 multiple lymph node miRNA overexpression - - - Patient study phenotype-control quantitative PCR
18442408 Ovarian cancer - 604370 (Epithelial ovarian cancer - 0) Cancer ovary cancer cell miRNA overexpression - 8.15 - Patient study phenotype-phenotype quantitative PCR
17942673 Duchenne muscular dystrophy - 310200 Muscular muscle miRNA overexpression - 8.56 - Patient study phenotype-control miRNA microarray
17942673 Muscular - 0 (muscular dystrophy, facioscapulohumeral - 0) Muscular muscle miRNA overexpression - 4.85 - Patient study phenotype-control miRNA microarray
17942673 Muscular dystrophy, limb-girdle, type 2A - 253600 Muscular muscle miRNA overexpression - 6.33 - Patient study phenotype-control miRNA microarray
17942673 Muscular dystrophy, limb-girdle, type 2B - 253601 Muscular muscle miRNA overexpression - 7.77 - Patient study phenotype-control miRNA microarray
17942673 Miyoshi myopathy - 254130 Muscular muscle miRNA overexpression - 4.39 - Patient study phenotype-control miRNA microarray
17942673 Myopathy, nemaline, 3 - 161800 Muscular muscle miRNA overexpression - 30.09 - Patient study phenotype-control miRNA microarray
17942673 Muscular - 0 (Dermatomyositis - 0) Muscular muscle miRNA overexpression - 4.53 - Patient study phenotype-control miRNA microarray
17998940 Cervical cancer, somatic - 603956 Cancer CaSki cell miRNA downregulation - 7.6 - Cell culture study miRNA microarray
17998940 Cervical cancer, somatic - 603956 Cancer HeLa cell miRNA downregulation - 5.6 - Cell culture study miRNA microarray
17976522 Myelofibrosis, idiopathic - 254450 Hematological granulocyte miRNA overexpression - 10.02 - Patient study phenotype-control quantitative PCR
18307259 Hepatocellular carcinoma - 114550 (Hepatocellular carcinoma, associated with hepatitis B/C viral infection and cirrhosis - 0) Cancer liver miRNA downregulation - 25.0 - Patient study phenotype-control quantitative PCR
18728182 Immunological - 0 (Monoclonal gammopathy of undetermined significance (MGUS) - 0) Immunological plasma cell miRNA overexpression - 6.9 - Patient study phenotype-control miRNA microarray
18728182 Multiple myeloma - 254500 Cancer plasma cell miRNA overexpression - 9.03 - Patient study phenotype-control miRNA microarray
16754881 Breast cancer - 114480 Cancer breast epithelium miRNA overexpression - - - Patient study phenotype-control array CGH
16754881 Melanoma and neural system tumor syndrome - 155755 Cancer cell culture miRNA downregulation - - - Cell culture study array CGH
17761882 Parkinson disease - 168600 Neurological cerebellar cortex miRNA downregulation - 1.53846 - Patient study phenotype-control quantitative PCR
17761882 Parkinson disease - 168600 Neurological cerebellum miRNA overexpression - 3.2 - Patient study phenotype-control quantitative PCR
17922033 Cancer - 0 (Leiomyosarcoma - 0) Cancer muscle miRNA downregulation - 12.5 - Patient study phenotype-control quantitative PCR
16192569 Breast cancer - 114480 Cancer MDA-MB-231 cell miRNA downregulation - 100.0 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer MDA-MB-361 cell miRNA downregulation - 100.0 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer DU-145 cell miRNA downregulation - 100.0 - Cell culture study quantitative PCR
16192569 Squamous cell carcinoma, head and neck - 601400 Cancer squamous cell carcinoma cell line miRNA downregulation - 100.0 - Cell culture study quantitative PCR
16192569 Squamous cell carcinoma, head and neck - 601400 Cancer squamous cell carcinoma cell line miRNA downregulation - 100.0 - Cell culture study quantitative PCR
16737555 - - fibroblast miRNA overexpression - - - Bioprocess study miRNA microarray
16192569 Pancreatic cancer - 260350 Cancer PANC-1 cell miRNA downregulation - 50.0 - Cell culture study quantitative PCR
16192569 Hematological - 0 Hematological K-562 cell miRNA downregulation - 12.5 - Cell culture study quantitative PCR
18607389 - - embryo miRNA overexpression - 1.28 - Bioprocess study quantitative PCR
16192569 Lung cancer - 211980 Cancer A-549 cell miRNA downregulation - 100.0 - Cell culture study quantitative PCR
17191223 - - lung miRNA downregulation - - - Bioprocess study quantitative PCR